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Abstract
Neurons that connect mechanosensory hair cell receptors to the central nervous system derive from the otic vesicle from where otic
neuroblasts delaminate and form the cochleovestibular ganglion (CVG). Local signals interact to promote this process, which is autonomous
and intrinsic to the otic vesicle. We have studied the expression and activity of insulin-like growth factor-1 (IGF-1) during the formation
of the chick CVG, focusing attention on its role in neurogenesis. IGF-1 and its receptor (IGFR) were detected at the mRNA and protein
levels in the otic epithelium and the CVG. The function of IGF-1 was explored in explants of otic vesicle by assessing the formation of the
CVG in the presence of anti-IGF-1 antibodies or the receptor competitive antagonist JB1. Interference with IGF-1 activity inhibited CVG
formation in growth factor-free media, revealing that endogenous IGF-1 activity is essential for ganglion generation. Analysis of cell
proliferation cell death, and expression of the early neuronal antigens Tuj-1, Islet-1/2, and G4 indicated that IGF-1 was required for survival,
proliferation, and differentiation of an actively expanding population of otic neuroblasts. IGF-1 blockade, however, did not affect NeuroD
within the otic epithelium. Experiments carried out on isolated CVG showed that exogenous IGF-1 induced cell proliferation, neurite
outgrowth, and G4 expression. These effects of IGF-1 were blocked by JB1. These findings suggest that IGF-1 is essential for neurogenesis
by allowing the expansion of a transit-amplifying neuroblast population and its differentiation into postmitotic neurons. IGF-1 is one of the
signals underlying autonomous development of the otic vesicle.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The number and type of neurons in the nervous system
are strictly regulated by the coordinated action of intrinsic
and extrinsic factors. Mechanisms involved in neuronal
specification and those linking cell proliferation with cell
fate are currently under intense research (Eddison et al.,
2000). Ear neurons are generated during early development,
in parallel with formation of the otic vesicle. The otic
vesicle is a transient structure that undergoes multiple de-
velopmental changes associated with cell proliferation, dif-
ferentiation, and death that build up the complexity, of the
inner ear. The otic vesicle shows developmental autonomy,
meaning that it can be explanted from the embryo to un-
dergo morphogenesis and differentiation of all cell types,
including mechanotransducing hair cells and the neurons
that connect hair cells to the central nervous system
(Represa et al., 1988; Swanson et al., 1990). Neuronal fate
is most probably specified within the neurosensory epithe-
lium during formation of the otic cup, through a mechanism
involving the Delta-Notch pathway (Adam et al., 1998).
After neuroblasts are singled out from the neural-sensory
domain of the otic vesicle, they delaminate and form the
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cochleovestibular ganglion (CVG) (Hemond and Morest,
1991; Adam et al., 1998). Auditory and vestibular neurons
then extend projections to innervate sensory patches and
central nuclei, and are selected for survival through a target-
dependent mechanism (Schimmang et al., 1995).
Insulin-related factors are members of a family of small
structurally related proteins, highly conserved throughout
evolution, which have multiple effects on embryonic cells.
Insulin-like growth factor-1 (IGF-1) acts through the type 1,
high-affinity IGF tyrosine-kinase receptor (IGFR), being
IGF-1 activity modulated by IGF binding proteins (Ferry et
al., 1999). IGF-1 and its receptor are expressed in many
regions from early stages of nervous system development in
chick and rodents (Bondy et al., 1990; De Pablo and de la
Rosa, 1995). Selective overexpression of IGF-1 in the ro-
dent brain causes an increase in neuron number and regional
density of myelinated axons (Behringer et al., 1990; Carson
et al., 1993; Ye et al., 1995). Conversely, igf-1 gene dis-
ruption produces loss of neuronal brain subpopulations as
well as selective central and peripheral hypomyelination
(Baker et al., 1993; Beck et al., 1995; Cheng et al., 1998).
Endogenous IGF-1, alone or in combination with other
diffusible factors, has diverse roles in the nervous system
(Varela-Nieto, et al., 2003). For example, IGF-1 is required
to promote proliferation and survival of neuroepithelial
cells, to induce sphere formation in stem cell cultures, and
for their differentiation to neurons (Drago et al., 1991;
Arsenijevic et al., 2001; Brooker et al., 2000). In addition,
neurogenesis in the adult rat hippocampus can be activated
by IGF-1 (Aberg et al., 2000; Trejo et al., 2001). IGF-1
therefore promotes either cell proliferation or cell differen-
tiation depending on the cellular context and cross-talk with
other extrinsic factors.
In vitro experiments and knockout mouse analysis sug-
gest that IGF-1 participates in the development of the inner
ear (Leo´n et al., 1995; Oesterle et al., 1997; Zheng et al.,
1997; Camarero et al., 2001, 2002). Newborn IGF-1-defi-
cient mice show reduced cochlear ganglion size and a sig-
nificant decrease in the number and size of postnatal audi-
tory neurons (Camarero et al., 2001, 2002). Furthermore, a
mutation in the Igf-1 gene in man is associated with senso-
ry-neural deafness (Woods et al., 1996, 1997). In vitro
treatment with IGF-1 promotes cell proliferation and sur-
vival of explanted otic vesicles (Leo´n et al., 1998; Frago et
al., 2003; Sanz et al., 1999).
In the present study, we have analyzed the role of IGF-1
Fig. 1. Interference of endogenous IGF-1 activity inhibits CVG neurogenesis. Photomicrographs show otic vesicles of stage 18 embryos cultured for 24 h
in serum-free media with no additions (0S, upper row), with anti IGF-1 antibody (1:100; middle row), or with the receptor inhibitor JB1 (20 g/ml; lower
row). First column shows freshly isolated ganglia (0 h). CVG are always oriented to the right (arrows).
Table 1
IGF-1 interference and CVG growth
Number of
explants
Average
 105 cm2
Mode
 105 cm2
160
 105 cm2
160
 105 cm2
No
CVG
OS 34 134  33 162 30 4 0
anti-IGF-1 (1:00) 34 85  29 70 8 19 7
JB1 (20 g/ml) 34 68 42 92 7 20 7
Note. The table summarizes data from 8 different experiments; the total number of explants tested per condition was 34. CVG surface area in single explants
was calculated as described in materials and methods and is presented as distribution around the 0S CVG mode (162  105 cm2). Otic vesicles with no
detectable ganglion were included in the sample to get the mode, but excluded for that of the average. Calibration bar, 150 m.
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in ear neurogenesis. Our results show that: (1) endogenous
IGF-1 is necessary to support survival and proliferation of
neuronal precursors, (2) IGF-1 is required for the mainte-
nance of neuroblast phenotype, (3) IGF-1 is able to induce
the transition into the postmitotic neuronal phenotype, and
(4) IGF-1 and its high affinity receptor are expressed in the
otic epithelium and CVG. Thus, IGF-1 emerges as an im-
portant factor for expansion of the ear neuroblast population
and their transit into postmitotic neurons.
Materials and methods
Organotypic culture of otic vesicle and CVG
Chicken embryos were obtained from fertilized eggs
from a local farm that were incubated at 38°C in a humid-
ified atmosphere. The embryos were staged according to
Hamburger and Hamilton criteria (Hamburger and Hamil-
ton, 1951). Otic vesicles were dissected from embryos cor-
responding to stage 18, transferred into four-well culture-
plates (NUNC, Roskilde, Denmark), and incubated at 37°C
in a water-saturated atmosphere containing 5% CO2 as
described (Leo´n et al., 1995). The standard culture medium
consisted of M199 medium with Earle’s salts (BioWhit-
taker, Walkersville, MD) supplemented with 2 mM glu-
tamine (BioWhittaker), antibiotics (50 IU/ml penicillin and
50 g/ml streptomycin; Biochrom; Berlin, Germany), and
10% fetal bovine serum (Gibco, Paisley, UK). In some
experiments explants were maintained in this medium with-
out serum, a condition termed “OS.” CVG were obtained
from stage 19–20 chick embryos, aseptically dissected, ex-
planted into collagen gel (Biochrom), and cultured with
0.25 ml F12/Dulbecco’s modified Eagle medium (Gibco)
containing 100 g/ml transferrin, 16 g/ml putrescine, 6
ng/ml progesterone, 5.2 ng/ml sodium selenite (all from
Sigma), and antibiotics as above. Human insulin-like
growth factor-1 (IGF-1) was purchased from Roche (Mann-
heim, Germany). Chicken insulin human IGF-1, and
chicken IGF-1 are equally potent on the otocyst (Leon et al.,
1998). Mouse NGF and bovine insulin were also from
Roche. JB1 is a peptide analogue of IGF-1 that specifically
binds the IGF high affinity receptor (Pie¨trzkowski et al.,
1992) and was supplied by IBT (Reutlingen, Germany).
Anti-IGF-1 rabbit polyclonal antibody was the kind gift of
Drs. L. Underwood and J.J. Van Wyk (University of North
Carolina, Chapel Hill, NC), distributed through the National
Hormone and Pituitary Program (NIDDK, Baltimore, MD).
Cross-reactivity of this antibody is 0.5% with human IGF-2
and negligible with human insulin (NIDDK information). It
binds efficiently to chicken IGF-1 but not to chicken insulin
(Robics et al., 1991; Leon et al., 1995).
Analysis of ganglia and data statistics
The area of the ganglia generated in otic vesicle organo-
typic cultures was estimated by following sterological meth-
ods (Camarero et al., 2001). Briefly, a grid was projected
onto photomicrographs taken with a Nikon TMS micro-
scope equipped with a  10 objective and a Nikon HFX-D
camera. Areas were estimated following the formula a
 Pi a(p), where a(p) is the area associated to each test
point [a(p)  0.0027 mm2], and Pi is the number of points
that fall within the CVG on each microphotograph. The
mean control CVG area was estimated from 20 CVG under
control culture conditions (OS) and was 134  3.3  105
cm2. Thirty-four explants per experimental condition were
tested. ANOVA was used to assess significance of the data
where indicated.
Immunoblotting
For Western blotting CVG-explants were homogenized
in SDS-PAGE sample buffer with 1 mM phenylmethylsul-
fonyl fluoride. Gels were loaded with equal amounts of
proteins, typically two CVGs per condition, and CVG pro-
teins were resolved by using SDS-PAGE and transferred
Fig. 2. Expression of PCNA and neuronal markers during CVG neurogen-
esis. Photomicrographs show sagittal (A–E and C) and coronal (F) cryo-
sections of stage 18 (A, B) and stage 21 (C–G) chick embryos. Prolifera-
tion-associated antigen PCNA (A, green) is expressed in scattered cells in
the ventral–anterior aspect of the otic vesicle, and in the CVG proximal to
the otic epithelium. Islet 1/2 (B–E, red) is expressed in the CVG from stage
18 to 21. Expression was restricted to neuroblasts in the proximal region of
the otic vesicle at HH18 (B), whereas at HH21, it was associated with
neuroblasts in the intermediate region of the CVG. (C) Double labeling for
Islet 1/2 (red) and IGFR (green) expression; yellow indicates positive
immunoreactivity for both markers. (D, E) Double-labeling for Islet 1/2
(red) and G4 (green). The neuronal marker G4 is expressed in the distal
differentiated neurons of the CVG. Tuj-1 expression (F, green) was ob-
served in ganglion cells extending processes into the otic epithelium at the
site of the future sensory patch but not in the epithelial cells. 3A10 (G,
green) expression coincided with G4 (D, E, green). A, anterior; D, dorsal.
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onto PVDF membranes (Dupont-NEN, Boston, MA). Fil-
ters were blocked with Tris-buffered saline containing 5%
(w/v) non-fat dried milk, and incubated with the specific
primary antibody. Bound peroxidase activity was visualized
by chemiluminiscence (Dupont-NEN) and quantified by us-
ing the NIH-Image 1.59 program. Mouse monoclonal anti-
proliferative cell nuclear antigen (PCNA) (ATOM, Barce-
lona, 1:2000 dilution) was used to recognize PCNA, a
marker of the S-phase of the cell cycle (Bravo and Mac-
Donald Bravo, 1987), whereas anti G4 (mouse ascites,
1:5000 dilution) antibodies were used to detect the axonal
glycoprotein G4 (Hernandez-Sanchez et al., 1995). Mouse
monoclonal anti--tubulin (mouse ascites, 1:1000 dilution;
Sigma, St. Louis, MO) was used as a loading control.
Secondary antibodies conjugated with peroxidase were pur-
chased from Bio-Rad (Hercules, CA).
In situ hybridization
Whole-mount in situ hybridization was performed as
described (Henrique et al., 1995) by using digoxigenin-
labeled RNA probes for chicken IGF-1 and IGFR, and
detected with NBT/BCIP. A single-stranded antisense
IGF-1 RNA probe was prepared by in vitro transcription of
pGEM-3Z-IGF-1 (Kajimoto and Rotwein, 1989) linearized
with HindIII using T7 RNA polymerase (Promega,
Southampton, UK). The chicken IGFR antisense RNA
probe was synthesized by using pGEM-4Z-IGFR (de la
Rosa et al., 1994) linearized with XbaI using SP6 RNA
polymerase (Promega). Control sense probes were gener-
ated with EcoRI using SP6 polymerase or with EcoRI using
T7 polymerase from pGEM-3Z-IGF-1 and pGEM-4Z-
IGFR, respectively. The NeuroD probe was from Ander-
son’s lab. Antisense probe was generated by plasmid lin-
earization with EcoRI and transcribed with T3 RNA
polymerase (Roche). For histological examination hybrid-
ized embryos were postfixed in 4% paraformaldehyde, em-
bedded in gelatin-albumin, and sectioned with a vibratome
(Leica VT 1000 M, Heidelberg, Germany) at a thickness of
60 m. At least 10 embryos per condition were analyzed in
3 different experiments.
Immunohistochemistry
Whole embryos were fixed overnight in 4% (w/v) parafor-
maldehyde at 4°C, cryoprotected in 30% sucrose, sectioned at
25 m with a Cryocut 1880 Leitz cryostat (Jena, Germany),
placed on poly-L-lysine-coated slides and stored at 20°C.
When indicated, immunohistochemistry was performed on
cryostat sections of cultured otocysts. Sources, dilution, and
cell specificity of antibodies were as follows: anti-PCNA
mouse mAb (Concepta, Barcelona, Spain, 1:400) mouse anti-
Islet 1/2 mAb (Developmental Studies Hybridoma Bank
1:200), mouse anti-Tuj-1 mAb (Lee et al., 1990; 1:200), rabbit
anti-G4 pAb (Rathjen et al., 1987; Hernandez-Sanchez et al.,
1995; 1:1000), mouse anti-BEN mAb (Developmental Studies
Hybridoma Bank; 1:200) mouse anti-3A10 pAb (Srinivasan et
al., 1998; 1:500), rabbit anti-IGF-1 pAb (NIDDK, Baltimore,
Fig. 3. Interference by endogenous IGF-1 activity reduces PCNA levels and induces loss of neuronal phenotype in CVG neuronal precursors. Otic vesicle
explants were isolated in stage 18 and incubated 24 h in the absence of serum (0S) (A, D), and in the presence of JB1 (20 g/ml) (B, E) or anti-IGF-1 (1:100)
(C). Upper panels show G4 and Islet 1/2 levels (green and red, respectively). Lower panels show PCNA and G4 levels (red and green, respectively). (F) A
schematic drawing of the expression pattern of the different markers in the CVG and neurogenic otic epithelium (A, D, and Fig. 2). Confocal laser scanning
microphotographs of 25-m cryosections are representative of nine otic vesicles (three independent experiments with three otic vesicles). Scale bars: small
images, 250 m; A–E, 50 m.
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USA; 1:300), and rabbit anti-IGFR pAb (Santa Cruz Biotech-
nology, Santa Cruz, CA, 1:200).
For single immunostaining, whole embryos or sections
were incubated for 2 h in a biotinylated anti-mouse or
anti-rabbit secondary antibody (1:400; Promega), processed
with ExtrAvidin-peroxidase conjugate solution (1:100;
Sigma), and peroxidase activity visualized with DAB. For
double-fluorescence immunolabeling sections were incu-
bated for 1 h with a mixture of Alexa Fluor 488 anti-rabbit
antibody (1:200) and Alexa Fluor 594 anti-mouse antibody
(1:200; both from Molecular Probes, Eugene, OR). Control
sections were incubated with preimmune serum and pro-
cessed as described above. Sections were dehydrated and
mounted in the mounting medium Entellan (Merck, Darm-
stadt, Germany). Microphotographs were taken in a Zeiss
microscope Axiophot, scanned with a Nikon CoolscanII,
using Adobe Photoshop 5.5 to produce computer-generated
photomicrographs. Fluorescence was analyzed in a
MRC1024 BioRad confocal microscope. At least eight em-
bryos or explants were analyzed for each condition in three
independent experiments.
TUNEL labeling
Distribution of apoptotic cells in the otic vesicle was
determined by Tdt-mediated dUTP nick-end labeling
(TUNEL) of the fragmented DNA adapted to whole organ
labeling (Frago et al., 1998, 2003). Briefly, otic vesicles
were fixed overnight with 4% (w/v) paraformaldehyde in
0.1 M PBS, pH 7.4, and permeated by four incubations with
1% (w/v) Triton -100 in PBS for 30 min at room temper-
ature and one incubation with 20 g/ml proteinase K
(Roche Molecular Biochemicals) for 10 min at 37°C. The
otic vesicles were then incubated with the terminal de-
oxynucleotidyl-transferase buffer for 30 min at 37°C, and
subsequently incubated with 0.1 U/l terminal deoxynucle-
otidyl-transferase and 10 M biotin-16-deoxy-UTP (Roche
Molecular Biochemicals) for 2.5 h at 37°C. The reaction is
stopped by incubation with 2 mM EDTA in PBS for 1 h, at
65°C. TUNEL labeling was visualized by incubation with
Cy2-streptavidin (Amersham Pharmacia Biotech, Rainham,
Essex, UK), which was followed by transparentation with
70% glycerol in PBS (v/v) and mounting for epifluores-
cence. Fluorescence was analyzed in a MRC1024 BioRad
confocal microscope. At least five otic vesicles per condi-
tion were assayed in five different experiments.
Results
Neutralization of endogenous IGF-1 action blocks
neurogenesis in the CVG
The CVG is formed by delamination of neuroblasts from
the neurosensory epithelium of the otic vesicle. The process
is complete by stage 20–21 and it is a very high activity at
stage 18 (D’Amico-Martel, 1982; Hemond and Morest,
1991). Explanted otic vesicles (HH18) cultured in the ab-
sence of serum or growth factors for 24 h reach quiescence.
An interesting and yet unexplained observation is that, un-
der these conditions, cell delamination and CVG formation
still take place (Leo´n et al., 1995). To assess whether this
autonomy is related to local IGF-1 secretion by the otic
vesicle we trapped endogenous IGF-1 with an anti-IGF-1
antibody or interfered with IGF-1 binding with the receptor
competitive antagonist JB1 peptide. The later is an IGF-1
analogue that contains a receptor-binding sequence of
IGF-1 and competes for IGFR binding (Pietrzkowski et al.,
1992). As shown in Fig. 1 and Table 1, incubation with
anti-IGF-1 antibody resulted in a reduction of the CVG.
Fifty-six percent of treated otic vesicles developed a smaller
CVG with respect to control ganglia, and 21% showed no
ganglia at all (compare first and second rows in Fig. 1 and
Table 1). Treatment with JB1 rendered similar effects; 21%
of otic vesicles showed no distinguishable CVG, and 68%
exhibited smaller ganglia after 24 h (third row in Fig. 1 and
Table 1). Simultaneous treatment with JB1 and anti-IGF-1
had no appreciable consequences, probably because the
anti-IGF-1 antibody recognizes and binds the JB1 peptide
(not shown). These experiments indicate that CVG forma-
tion depends on the endogenous expression and activity of
IGF-1 in the otic vesicle.
IGF-1 is required for cell proliferation and maintenance
of the neuronal phenotype
The effects of IGF-1 were further explored by studying
the expression pattern of several cell markers, including
PCNA, Tuj-1, BEN, Islet 1/2, 3A10, and G4. There is a
spatial–temporal expression pattern of these proteins in the
CVG (Fig. 2). The sequence displayed in a proximal–distal
pattern was, with reference to the otic vesicle: PCNA, then
Islet 1/2 and Tuj-1 that preceded G4 and 3A10. Stage 18
otic vesicles and cells within the CVG expressed the cell
proliferation marker PCNA (Fig. 2A). PCNA-positive cells
in the CVG were proximal to the otic vesicle and adjacent
to positive cells, within the epithelium. The PCNA domain
partially overlapped that of Islet 1/2 (Fig. 2B, see also Fig.
3D). By stage 21, the wave of Islet 1/2-positive cells was
displaced distally to the otic vesicle (from posterior/caudal
to anterior/rostral), leaving behind cells that although less
intensely also expressed Islet 1/2 (Fig. 2D and E, red). The
more distal Islet 1/2-positive cells also expressed the post-
mitotic neuronal antigen G4 (Fig. 2D and E, green). Islet
1/2-positive cells also expressed IGFR (Fig. 2C). Other
neuronal markers are compared with Islet 1/2 in Fig. 2 (F
and G). Tuj-1 overlapped with Islet 1/2 (Fig. 2F), BEN was
expressed intensely in the CVG and in the otic epithelium
(data not shown; see Adam et al., 1998), and 3A10 was
distal to Islet 1/2 (Fig. 2G), in a pattern similar to that of G4.
The spatial sequence was PCNA  Islet 1/2  Tuj-1  G4
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 3A10, and it may also reflect the temporal sequence of
neuronal maturation.
PCNA, Islet 1/2, and G4 were used preferentially to
analyze the phenotype of ganglion cells of otic vesicles that
were treated with anti IGF-1 antibody or JB1 (Fig. 3). We
selected otic vesicles that were partially blocked by the
antibody or JB1 (and not those with complete inhibition) so
we could study a moderate phenotype and follow the be-
havior of otic neuroblasts. Fig. 3 shows representative ex-
periments of otic vesicles that were cultured in standard
medium without fetal serum, with no addition (OS) with
JB1, or with anti-IGF-1. Again, the size of the CVG that
were treated with JB1 or anti IGF-1 was reduced (compare
control A and D with blocked B, C, and E), and this was
associated with a reduction in PCNA expression (Fig. 3E,
red), indicating cell division arrest. The neuronal phenotype
of cells that remained in the ganglion was lost. Control
explants showed the described pattern of proximal–distal
PCNA, Islet 1/2, and G4 expression (Fig. 3A and D, and
scheme in F). But when IGF-1 activity was blocked, Islet
1/2 expression was strongly reduced (Fig. 3B and C, red; n
 8 different otic vesicles). Islet 1/2 and G4 expression
remained positive within the most distal part of the CVG (B,
C, and E, green).
If neuroblasts depend on IGF-1 to maintain their neuro-
nal phenotype, then neuronal markers that were lost by JB1,
like G4, should be rescued by exogenous IGF-1. To test this
possibility, otic vesicles were treated with JB1 for 24 h,
washed for 2 h, and then cultured for a further period of 24 h
with IGF-1 (Fig. 4). After incubation, explants were ana-
lyzed with the anti-G4 (A, D, G) and for Tuj-1 (B, E, H)
antibodies to assess for neuronal fate, and double-labeled
with the anti-phospho-histone H3 antibody to assess for cell
proliferation. Otic vesicles that were blocked with JB1 (Fig.
4B) showed a lower expression of G4 and Tuj-1 than con-
trol otic vesicles (OS, Fig. 4A vs D for G4 and B and E for
Tuj-1), with G4 and Tuj-1 being always distal to the otic
vesicle (n  12). When exogenous IGF-1 was added to
IGF-1-blocked explants, G4 and Tuj-1 were intensely ex-
pressed in the CVG and the proximal–distal differentiation
pattern was lost (Fig. 4G for G4 and H for Tuj-1). In
parallel, cell proliferation was arrested in the CVG by JB1
(Fig. 4F) and restored above levels in OS by the addition of
IGF-1 (compare OS in Fig. 4C with IGF-1 in Fig. 4I).
IGF-1, therefore, was required for cell proliferation of gan-
glionar neuroblasts, to rescue the neuronal phenotype and to
shift the ganglionic cell population to a postmitotic neuronal
phenotype.
IGF-1 promotes transition into the post-mitotic stage of
neuronal development
To determine whether IGF-1 effects on the transition
from neuroblasts into neurons were direct or mediated by an
epithelial-derived factor, cultured ganglion explants treated
with exogenous IGF-1 were examined with cell prolifera-
tion and differentiation markers. Ganglia were isolated at
stage 19–20 (70–72 h) and cultured on a collagen substrate.
Fig. 5A illustrates one of the experiments in which ganglia
were incubated in control medium (OS), with IGF-1 alone
(IGF-1), or in the presence of JB1 (IGF-1  JB1). A low
rate of neurite outgrowth was observed in control ganglia,
the number of labeled processes was nonetheless much
greater in the presence of IGF-1. High G4 labeling intensity
was also apparent in the core of IGF-1-treated ganglia
compared with the control (Fig. 5A). The effects of IGF-1
on PCNA and G4 expression were quantified by Western
blotting of isolated CVG (Fig. 5B). IGF-1 treatment in-
creased PCNA levels and the expression of the neuron-
specific antigen G4 by four- and three-fold, respectively.
-Tubulin was used as a loading control. Human IGF-1 and
chicken insulin were equally potent in stimulating. CVG
proliferation (not shown), as reported for cultured otic vesicles
(Leon et al., 1998). The effect of IGF-1 on G4 expression was
not mimicked, however, by other factors, such as chicken and
bovine insulin or nerve growth factor (not shown). The spec-
ificity of IGF-1 action was assessed by cotreatment with JB1,
which effectively blocked IGF-1 induced cell proliferation and
differentiation (Fig. 5B), confirming that exogenous IGF-1 acts
specifically through its high affinity receptor.
IGF-1 is required for cell-survival but not for cell fate
specification or delamination
We questioned now whether the requirement of IGF-1
for the formation of the CVG occurred at early stages of
neuronal cell-fate specification and delamination of young
neuroblasts, or once they migrate to the CVG. The proneu-
ral gene Neuro D was used as a marker for early born
neuroblasts and analyzed in experiments similar to those
described above (Figs. 1 and 3). Fig. 6A shows that block-
ade of IGF-1 either by anti-IGF-1 antibody or JB1 induced
a reduction in the size of the ganglion, which maintained the
expression of NeuroD. The extension or intensity of Neu-
roD expression within the neurosensory domain of the otic
vesicle (ns) was unaffected (n  5). This indicates that
interference with IGF-1 does not affect cell determination or
the mechanism of neuroblasts delamination.
One important question is whether or not IGF-1 is re-
quired for survival of neuroblasts in the CVG. This was
studied by measuring cell death by the TUNEL assay. Fig.
6B shows the results of a typical experiment (n 24) where
cell death increased in the CVG after interference with
IGF-1 and whereas it was protected by IGF-1. Cell death
labeling was high in the JB1-blocked otic vesicles after 24-
and 48-h incubations (Fig. 6B, JB1 24h and JB1 48h). IGF-1
abolished completely cell death when present in the incu-
bation media alone (Fig. 6B, IGF-1 48h) and it attenuated
the effect of JB1 when JB1 was washed and otic vesicles
were reincubated with IGF-1 (Fig. 6B, JB1, IGF-1), indi-
cating that cell survival was strongly dependent on IGF-1.
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IGF-1 and its high affinity receptor are expressed in the
otic vesicle and the CVG
Previous work showed IGF-1 immunoreactivity and high
affinity binding of 125I-IGF-1 to specific receptors in the otic
vesicle in HH20 chick embryos (Leon et al., 1995). In the
present work, we extended the study to the expression of
IGF-1 and its high affinity receptor during formation of the
CVG. IGF-1 mRNA and protein were expressed in the otic
cup stages (Fig. 7A–C, sense probe in D) and the otic
vesicle (Fig. 7E and F, inset in F1 was processed without the
first antibody). By stage 20, the neurogenic epithelium and
the CVG showed IGF-1 immunoreactivity (Fig. 7F, arrow-
head). Other cranial ganglia like the trigeminal ganglia were
also positive to IGF-1 (Fig. 6E). IGF-1 receptor expression
detection with an anti-IGFR antibody (Fig. 7G and I) and a
chicken IGFR probe (Fig. 7G) revealed that IGFR domain
broadly overlapped with that of IGF-1. In stage-16, IGFR
protein was detected in the otic cup, less intensely at the edges
(Fig. 7G). By stage 18–20, IGFR was expressed in the otic
epithelium epithelium, including the ventral–anterior aspect
that contains the neural-sensory domain (arrowheads), and the
CVG (Fig. 7I). IGFR mRNA was less intense in the medial
and ventral aspects of the otic vesicle (not shown).
Discussion
Otic neuroblasts are singled out from a common sensory
neural field and delaminate from the ventral aspect of the
otic vesicle to populate the CVG. The mechanisms respon-
sible for the initial steps in the specification of auditive
neurons are starting to be analyzed, and the Delta-Notch
pathway seems to be involved in the selection of early
neuronal precursors (Adam et al., 1998). The differentiation
and survival of ear neurons have been studied in detail, and
the role of neurotrophins in maintaining target-derived sur-
vival has been documented (Schimmang et al., 1995; Torres
and Giraldez, 1998). However, the mechanism by which the
early neuroblast population expands and transits into post-
Fig. 4. Exogenous IGF-1 rescues CVG neuronal phenotype and cell proliferation. Otic vesicles were first isolated (HH18) and incubated 24 h in the absence
of serum (0S, no addition) or in the presence of JB1 (20 g/ml; JB1). Secondly, they were washed for 2 h in PBS. Finally, 0S explants and JB1-treated
explants were then incubated 24 h in fresh medium without serum (0S), whereas a different batch of JB1-treated explants received IGF-1 (IGF-1, 1 nM)
for a further 24 h. Otic vesicles after 48 h are shown to the right in confocal laser microphotographs of the three conditions OS (A–C), JB1 (D–F), and
IGF-1 (G–I). From left to right, microphotographs correspond to panoramic views of G4 levels (A, D, G), Tuj-1 and phospho-histone H3 (B, E, H), and
a detail of the CVG labeled with Tuj-1 and phospho-histone H3 (C, F, I), and are representative of 12 otic vesicles (4 different experiments).
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mitotic neurons remains uncertain. Delamination and pro-
liferation of otic neuroblasts is an autonomous process, it
occurs in isolated otic vesicles in the absence of added
factors, and implies the activity of endogenous signals orig-
inated either in the otic epithelium, the CVG, or both. In our
previous work, we showed that IGF-1 is able to induce cell
proliferation in the otic vesicle and the CVG with greater
potency than insulin and IGF-2, and we have also explored
some of its molecular aspects of its lipid signaling mecha-
nisms (Leo´n et al., 1995, 1998; Frago et al., 2003). In this
report, we provide new data on the actions of IGF-1 on
neurogenesis and, more critically, we show that endogenous
IGF-1 is essential or cell survival and proliferation of neu-
roblasts when they emerge from the otic vesicle to populate
the CVG, where IGF-1 also promotes their differentiation
into otic neurons.
IGF-1 is not required for neuroblast specification or
delamination
Delamination of precursors from the otic vesicle is well
documented in quail/chick grafting experiments and was
recently confirmed by labeling cells with molecular markers
(Eddison et al., 2000; Torres and Giraldez, 1998). Neuro-
blasts express NeuroD, a tissue-specific basic helix–loop–
helix (bHLH) transcription factor that belongs to the pro-
neural atonal-like genes (Ledent and Vervoort, 2001).
NeuroD is expressed in the neurogenic domain of the otic
epithelium and the CVG, and is most probably expressed in
nascent neuroblasts (Alsina et al., 2003). IGF-1 inhibition
reduced the size of the CVG, and cell death occurs within
otic epithelium; however, this is not paralleled by the re-
duction of NeuroD-positive neuronal precursors, indicating
that IGF-1 is not essential for cell fate specification.
IGF-1 is not involved with the delamination machinery.
If this were so, it would be expected that IGF-1 blockade
induced an accumulation of NeuroD-positive precursors
within the neurogenic epithelium, and this does not seem to
be the case A recent study of mice carrying the BETA2/
NeuroD1 null mutation shows delayed delamination of otic
neuroblasts with no detectable effects on cell proliferation
or fate decision (Liu et al., 2000). Interestingly, BETA2/
NeuroD1 was cloned by its ability to upregulate insulin
gene expression (Naya et al., 1995). These results indicate
Fig. 5. Exogenous IGF-1 induces cell proliferation and neuronal differentiation in CVG explants. (A) Photomicrographs from embryonic day E3 (HH stage
19) CVG explants cultured on collagen gel in serum-free medium with no addition (0S), with 1 nM IGF-1 alone (IGF-1), or plus 10 g/ml JB1 (IGF-1 
JB1). G4 immunoreactivity is shown at the right in two representative explants (0S and IGF-1) of at least five independent experiments. (B) PCNA and G4
protein levels were analyzed by Western blotting in CVG explants cultured in control conditions or in the presence of IGF-1 or IGF-1 plus JB-1 at different
doses. A representative experiment of three and densitometric quantitation are shown. Protein levels are expressed relative to the control value taken as 1.
Statistical significance estimated by ANOVA was as follows: ***, P  0.001 and **, P  0.001 vs. IGF-1. -Tubulin was used as loading control.
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that cell migration can be dissociated from cell specification
and proliferation, but that a possible link exists between
genes that regulate these two processes. Possible interac-
tions between insulin-related factors and proneural genes in
the otic vesicle deserve further study.
IGF-1 is required for expansion and differentiation of
neuroblasts upon emerging from the otic vesicle
By using several neuronal antigen markers we describe a
spatial sequence of neuronal maturation. With respect to the
otic vesicle and from proximal to distal, neuroblasts express
first Tuj-1 and Islet 1/2, and then G4 and 3A10 at the most
distal end of the CVG. This spatial sequence probably
corresponds to the temporal order of neuron generation:
young-immature-proliferating neuroblasts concentrate prox-
imal to the otic vesicle, whereas postmitotic neurons reside
distally. Classical studies described a temporal sequence in
neuroblast migration from the otic epithelium CVG neuro-
blast migration is maximal by stage 17 and is finished by
stage 21 (Hemond and Morest, 1991). Final mitoses occur
between days 2.5 and 7 (stages 16-32) (D’Amico Martel,
1982). The anterior-most aspect of the CVG (distal to the
OV) is the first to express G4 and 3A10 (this study) and also
the first to show postmitotic cells and signs of cellular
differentiation (D’Amico-Martel, 1982; Hemond and Mor-
est, 1991).
The time lapse between migration (stg 21) and termi-
nal mitoses (stg 29) implies that most of the cellular
contingent of the CVG is still intermitotic and that the CVG
contains an expanding cell population of neuroblasts. This
is in agreement with our results showing that PCNA, phos-
pho-histone H3, and Islet 1/2 or Tuj-1 are coexpressed in the
CVG, and with a recent paper by Begbie et al. (2002). These
properties are consistent with those of transit amplifying
cells, those daughters of stem cells that are destined to
withdraw from the cell cycle and terminally differentiate
after a few rounds of division. Otic neurogenesis, therefore,
can be described by successive cell states probably regu-
lated differentially by intrinsic and extrinsic signals (Alsina
et al., 2003). First the specification of a population of pro-
genitor cells within the epithelial neural-sensory domain
giving rise to neuronal precursors (epithelial neuroblasts,
expressing NeuroD); Secondly, the delamination of neuro-
blasts; Thirdly, the expansion of a transit-amplifying popu-
lation of neuronal committed but still proliferative cells
(proximal, ganglionar neuroblasts, expressing PCNA,
Tuj-1, and Islet 1/2); Finally, the transition into postmitotic
neurons and the initiation of terminal differentiation (distal,
postmitotic immature neuronal precursors expressing G4
and 3A10).
When endogenous IGF-1 activity is blocked survival,
proliferation, and differentiation are impaired in those neu-
roblasts that delaminated from the otic vesicle and populate
the CVG. Cells within the ganglion were TUNEL-positive
and lacked PCNA, Islet 1/2, or Tuj-1 expression. IGF-1 is
unable to reverse advances stages of apotosis, as illustrated
in the experiments of Fig. 6B, but it attenuated the effects of
blockade and prevented cell death in the absence of serum.
IGF-1 reduces cell death and stimulates cells to proliferate,
acting on cells that are not yet apoptotic or that have not
entered at all in apoptosis, the activation being enough to
recover to a good extent the expansion of neuroblasts and
their progression toward postmitotic neurons. The specific-
ity of the effect of IGF-1 is demonstrated by the fact that the
generation of the CVG is aborted either by antibodies di-
rected against IGF-1 or by blocking IGFR1, the high-affin-
ity receptor for IGF-1, and by showing that the inhibition
elicited by IGF-1 blockade is reverted by treatment with
exogenous IGF-1. It is possible that the experimental ap-
proach, organotypic explants in culture does exaggerate a
requirement that in vivo may be compensated by other
factors and it better uncovers the action of IGF-1. With this
proviso, the results suggest that IGF-1 is required for sur-
vival of neuroblasts exiting from the otic vesicle, allowing
them to perform the cycles of cell division and transit into
postmitotic neurons. That IGF-1 acts directly on otic neu-
roblasts is indicated by the observation that it is able to
induce cell proliferation and differentiation on isolated
CVG, where no epithelial signal can mediate the effects.
An open question is whether IGF-1 allows cell survival
only or, in addition, it actively promotes cell proliferation
and expression of neuronal markers. The effect of IGF-1 on
neurite outgrowth and G4 fasciculin expression is robust
and several reports on the effects of IGF-1 on retinal and
central neurons have shown that IGF-1 is able to induce
neuronal differentiation (Frade et al., 1996; De Pablo and de
la Rosa, 1995; Anlar et al., 1999). IGF-1 has been shown to
promote proliferation survival, and maturation of sympa-
thetic neuroblasts and activation of neural precursor differ-
entiation (Arsenijevic and Weis, 1998). However, it is al-
ways difficult to assess the extent to which neuronal
phenotype is induced by IGF-1 or it is the consequence of
permissive action allowing the appropriate number of cell
division cycles. Neuroblasts may have intrinsic mechanisms
by which quiescence is related to the appropriate transition
of temporal identity genes as recently shown by Isshiki et al.
(2001). Transgenic mice that overexpress IGF-1 show a
dramatic increase in the total number of neurons (O’Kusky
et al., 2000). However, neonate mutant mice do not show an
abnormal number of cochlear neurons (Camarero et al.,
2000), which appears to clash with the observation that, in
the chick, neuronal survival and maturation of CVG neuro-
blasts are strictly dependent on IGF-1. In the particular case
of insulin-related factors and the development of the ear,
other factors such as insulin or IGF-2 may compensate for
the IGF-1 deficit (Baker et al., 1993; Leon et al., 1995,
1998; Burns and Hassan, 2001). Mice deficient in IGF-1,
have profound regulation of gene expression that allow
survival, and IGFR1 and IGF-2 are both upregulated in the
inner ear of IGF-1 null mouse (Varela-Nieto, unpublished).
Therefore, compensation is based not only on the occur-
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rence but also on the regulation of other related factors and
receptors. However, the situation is completely different in
the chick embryo, where IGF-1 actions are acutely abol-
ished in embryos with a normal expression of the factor and,
therefore, at the time of the experiment, there has not been
such compensation. On the other hand, our data in chick
embryos do not exclude that those cells that survive to
IGF-1 blockade are upregulating or basally expressing
IGF-2 or proinsulin. These factors will suffice for survival
but not for progressing into the differentiation program as
suggested by the experiments in cultured CVG and are in
agreement with the mouse data that indicate that the deficit
of IGF-1 is not compensated by other factors during the
final process of neuronal maturation. Another nonexcluding
possibility is the existence of substantial differences in the
identity of molecules acting in different species on a back-
ground of highly conserved mechanisms (see Manzanares et
al., 2001).
In conclusion, otic neuroblasts form a transit-amplifying
cell population after delamination from the otic vesicle and
before differentiation into postmitotic neurons. This devel-
opmental window is characterized by cell proliferation and
the expression of particular neuronal markers. IGF-1 is an
endogenous factor required for survival and expansion of
this neuroblast population. IGF-1 may allow the transit of
this cellular pool into postmitotic neurons, before the com-
mencement of their dependence on neurotrophins.
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